A first-in-human phase I study in patients with advanced and/or refractory solid
- This topic has 0 replies, 1 voice, and was last updated 3 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A first-in-human phase I study in patients with advanced and/or refractory solid malignancies to evaluate the safety of ATOR-1015, a CTLA-4 x OX40 bispecific antibody.
https://meetinglibrary.asco.org/record/188756/abstract
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.